Pay in 4 interest-free payments of $5.22 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
DSIP has become increasingly popular among peptide researchers interested in restorative biological signaling and neurophysiological pathway investigations
Common themes include rapid onset of anti-inflammatory effects (often within days), gradual improvement in function over weeks, and best results when combined with appropriate physical therapy and lifestyle modifications
BPC-157 primarily engages angiogenic signaling (VEGF pathway modulation) and nitric oxide system regulation, addressing vascularization limits in tendon healing
For the full BPC-157 dosing breakdown, see our BPC-157 dosage protocol guide: BPC-157: 200 to 500 mcg per day, subcutaneous injection near the injury site, 4 to 8 weeks TB-500 loading phase (Weeks 1-4): 2 to 5 mg twice per week TB-500 maintenance phase (Weeks 5-8): 2 mg once per week Route: Both peptides are administered via subcutaneous injection
For a deeper single-compound overview, see the BPC-157 Canada research guide
The "Research Chemical Only" Label If youve looked for BPC-157 online, youve likely seen it sold with a disclaimer like "for research purposes only" or "not for human consumption." This isn't just a suggestion
